Form 4: Allovir Inc. General Counsel Sells Shares to Cover Tax Obligations

Sentiment:

SEC Form 4


Edward Miller, General Counsel of Allovir, Inc., sold shares to cover tax withholding obligations related to vesting restricted stock units.

Summary

  • Edward Miller, the General Counsel of Allovir, Inc., reported the sale of common stock on October 21 and 22, 2024.
  • The sales were executed to cover tax withholding obligations associated with the vesting of restricted stock units.
  • On October 21, 2024, 635 shares were sold at a weighted average price of $0.779, with individual prices ranging from $0.7544 to $0.7964.
  • On October 22, 2024, 766 shares were sold at a weighted average price of $0.7678, with individual prices ranging from $0.76 to $0.7709.
  • Following these transactions, Miller directly owns 214,203 shares of common stock.
  • Miller also indirectly owns 288,799 shares through The Miller Family 2019 Irrevocable Dynasty Trust, but disclaims beneficial ownership except to the extent of his pecuniary interest.

Sentiment

Score: 6

Explanation: The sentiment is neutral. The document reports routine stock sales by an executive to cover tax obligations, which is a common practice and doesn't necessarily indicate a positive or negative outlook for the company.

Positives

  • The sales were conducted to cover tax obligations, which is a common practice when restricted stock units vest.

Industry Context

Sales of shares by company executives are a common occurrence, often related to compensation and tax obligations. These transactions are closely monitored by investors for insights into management's perspective on the company's value and future prospects.

Comparison to Industry Standards

  • Executive stock sales are a normal part of corporate compensation, especially in companies that offer stock options or restricted stock units.
  • Comparing Miller's transactions to similar sales by executives at comparable biotech companies like Gilead, Amgen, or Biogen would provide context on the scale and motivation behind these sales.
  • For example, if executives at similar companies are also selling shares to cover tax obligations, it reinforces the routine nature of these transactions.

Stakeholder Impact

  • The stock sales may have a minor impact on shareholders due to the increased supply of shares in the market, but the impact is likely to be minimal given the relatively small number of shares sold.

Key Dates

DateDescription
10/21/2024Sale of 635 shares of common stock.
10/22/2024Sale of 766 shares of common stock.
10/23/2024Date of signature for the Form 4 filing.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.